Skip to content
The Oxford Scientist

The Oxford Scientist

The University of Oxford's independent science magazine

Newsletter
  • Home
  • News
  • Opinion
  • Features
  • Culture
  • Schools Competition
    • About the competition
    • FAQs
    • Past Winners & Runners Up
      • Schools Writing Competition Michaelmas Term 2022
      • School’s Writing Competition Hilary Term 2021
      • Schools’ Writing Competition Trinity Term 2020
      • Schools’ Writing Competition Hilary Term 2020
      • Schools Writing Competition Michaelmas Term 2019
      • Schools Writing Competition Trinity Term 2019
      • Schools Writing Competition Hilary Term 2019
      • Schools Writing Competition Michaelmas Term 2018
      • Schools Writing Competition Hilary Term 2018
  • About Us
    • About Us
    • The Team
    • Our Sponsors
    • Contact Us
      • Subscriptions
      • Advertise With Us
    • Past Issues
    • Bang! Science Magazine Archives
  • Get Involved
    • Open Commissions
    • Pitch to us
  • Home
  • drug development

drug development

man's ear with hearing aid
  • Features

Ringing in the brain: tinnitus and the nervous system

Jamie AdamsMay 8, 2023May 11, 2023018 mins

Jamie Adams reviews what we know about tinnitus, and options for treating this mysterious medical condition.

Continue reading
A brown lab mouse sits on an experimenter's hand
  • Opinion

Are animal models still relevant to drug development?

Adèle BouyerMarch 1, 2023May 10, 2023014 mins

Adèle Bouyer reviews how a recent change in FDA regulation may herald a decline in animal testing, in the face of new alternative models.

Continue reading
Cartoon of a brain defended by the blood brain barrier against a stream of incoming objects
  • Barriers MT22
  • Features
  • Past Issues

Is the blood-brain barrier a barrier to medical progress?

Sophie BeaumontFebruary 17, 2023March 14, 2023015 mins

Sophie Beaumont reviews research into how the blood-brain barrier protects the brain, and poses challenges for delivery of medical treatment.

Continue reading
Cartoon of cancer immunotherapies
  • Barriers MT22
  • Features
  • Past Issues

Checkpoints: Progress in cancer immunotherapy

Cecilia JayFebruary 15, 2023March 21, 2023011 mins

Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .

Continue reading
illustration of neurons containing plaques and tau clusters as found in progressive supranuclear palsy
  • Features

Shining a light on progressive supranuclear palsy

Ayaka HoggJanuary 11, 2023March 18, 2023016 mins

Ayaka Hogg describes the discovery of progressive supranuclear palsy, and the challenges in treating this neurodegenerative disease.

Continue reading

Receive our Newsletter

* indicates required

Most Read

  • man's ear with hearing aid
    Ringing in the brain: tinnitus and the nervous system

  • sea urchins and brittlestar on a deep seamount
    New report exposes the impacts of deep sea mining

  • a lab rat
    Restoring gamma oscillations may treat depression

  • Elderly couple sitting on bench overlooking sea
    Rethinking death and ageing in the age of modern medicine

  • a newborn baby's feet
    WHO finds that 1 in 6 people experience infertility globally

Newsmatic - News WordPress Theme 2023. Powered By BlazeThemes.
  • About
  • Get Involved
  • Terms and Conditions
  • Cookie Policy (UK)
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}